ERBA DIAGNOSTICS
ERB
ERB was delisted on the 29th of September, 2016.
12 hedge funds and large institutions have $647K invested in ERBA DIAGNOSTICS in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
8% less funds holding
Funds holding: 13 → 12 (-1)
17% less capital invested
Capital invested by funds: $781K → $647K (-$134K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.72K |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$253 |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$39 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$12K |
| 2 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
-$1K |
ERB Hedge Fund Activity: Q2 2016 in Review
12 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ERBA DIAGNOSTICS (ERB) for Q2 2016, worth a combined $647K — down 17% from $781K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ERB and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, adding an estimated $1.72K. The largest seller was Segall Bryant & Hamill, exiting entirely with an estimated $12K sold.
- 12 institutional investors held ERBA DIAGNOSTICS (ERB) as of Q2 2016, down from 13 in Q1 2016.
- Funds reported $647K of ERBA DIAGNOSTICS stock for Q2 2016, down 17% quarter-over-quarter.
- 1 fund opened new ERBA DIAGNOSTICS positions in Q2 2016 and 2 closed out, a net change of -1 holder.
- The largest ERBA DIAGNOSTICS buyer in Q2 2016 was UBS Group, an estimated $1.72K added.
- The largest ERBA DIAGNOSTICS seller in Q2 2016 was Segall Bryant & Hamill, an estimated $12K sold.
Based on aggregated 13F filings for Q2 2016.